Loring Wolcott & Coolidge Fiduciary Advisors LLP MA maintained its position in shares of Monsanto Company (NYSE:MON) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 11,292 shares of the basic materials company’s stock at the close of the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Monsanto were worth $1,319,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Penserra Capital Management LLC lifted its position in Monsanto by 13.0% during the second quarter. Penserra Capital Management LLC now owns 1,456 shares of the basic materials company’s stock valued at $172,000 after purchasing an additional 168 shares in the last quarter. Prudential Financial Inc. lifted its position in shares of Monsanto by 1.0% in the second quarter. Prudential Financial Inc. now owns 635,345 shares of the basic materials company’s stock valued at $75,199,000 after acquiring an additional 6,120 shares in the last quarter. Great Lakes Advisors LLC lifted its position in shares of Monsanto by 1.7% in the second quarter. Great Lakes Advisors LLC now owns 12,520 shares of the basic materials company’s stock valued at $1,482,000 after acquiring an additional 209 shares in the last quarter. Iridian Asset Management LLC CT lifted its position in shares of Monsanto by 22.1% in the second quarter. Iridian Asset Management LLC CT now owns 15,575 shares of the basic materials company’s stock valued at $1,843,000 after acquiring an additional 2,815 shares in the last quarter. Finally, Zweig DiMenna Associates LLC purchased a new position in shares of Monsanto in the second quarter valued at about $3,253,000. Institutional investors own 74.79% of the company’s stock.
Shares of Monsanto Company (NYSE:MON) traded up 0.43% during mid-day trading on Friday, hitting $118.10. The stock had a trading volume of 1,135,248 shares. The stock’s 50-day moving average is $117.23 and its 200 day moving average is $116.41. The firm has a market cap of $51.88 billion, a PE ratio of 25.51 and a beta of 1.07. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $118.97.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period last year, the business earned $2.17 EPS. Equities research analysts predict that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be issued a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 1.84%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio is currently 46.75%.
A number of research firms recently commented on MON. UBS AG downgraded Monsanto from a “positive” rating to a “neutral” rating in a research report on Tuesday, June 27th. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research note on Thursday. BidaskClub cut Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Piper Jaffray Companies set a $128.00 price objective on Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. Finally, Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective on the stock in a research note on Tuesday, June 27th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $123.49.
In other news, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the transaction, the executive vice president now directly owns 55,011 shares in the company, valued at approximately $6,522,654.27. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with our FREE daily email newsletter.